Silibinin meglumine ameliorates hepatic encephalopathy via inhibiting UCP2-mediated oxidative stress and mitochondrial dysfunction

Keywords

Hepatic encephalopathy / Silibinin meglumine / Uncoupling protein 2 / Oxidative stress / Mitochondrial dysfunction / Mitophagy

Funding

This work was supported by “the National Science and Technology Major Project” from the Ministry of Science and Technology of the People’s Republic of China (No. 2017ZX09301050).

Declaration of competing interests

These authors have no conflict of interest to declare.

References

[1] Häussinger D, Dhiman RK, Felipo V, et al. Hepatic encephalopathy. Nat Rev Dis Primers. 2022; 8(1):43. https://doi.org/10.1038/s41572-022-00366-6.

[2] Louissaint J, Deutsch-Link S, Tapper EB. Changing epidemiology of cirrhosis and hepatic encephalopathy. Clin Gastroenterol Hepatol. 2022; 20(8S):S1-S8. https://doi.org/10.1016/j.cgh.2022.04.036.

[3] Rose CF, Amodio P, Bajaj JS, et al. Hepatic encephalopathy: novel insights into classification, pathophysiology and therapy. J Hepatol. 2020; 73(6):1526-1547. https://doi.org/10.1016/j.jhep.2020.07.013.

[4] Görg B, Karababa A, Schütz E, et al. O-GlcNAcylation-dependent upregulation of HO1 triggers ammonia-induced oxidative stress and senescence in hepatic encephalopathy. J Hepatol. 2019; 71(5):930-941. https://doi.org/10.1016/j.jhep.2019.06.020.

[5] Hu C, Zhang X, Wei W, et al. Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via maintaining AMPKα/UCP2 pathway. Acta Pharm Sin B. 2019; 9(4):690-701. https://doi.org/10.1016/j.apsb.2019.03.003.

[6] Li S, Sun D, Chen S, et al. UCP2-SIRT3 signaling relieved hyperglycemia-induced oxidative stress and senescence in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2024; 65(1):14. https://doi.org/10.1167/iovs.65.1.14.

[7] Padmanaban S, Pully D, Samrot AV, et al. Rising influence of nanotechnology in addressing oxidative stress-related liver disorders. Antioxidants (Basel). 2023; 12(7):1405. https://doi.org/10.3390/antiox12071405.

[8] Bai Y, Li K, Li X, et al. Effects of oxidative stress on hepatic encephalopathy pathogenesis in mice. Nat Commun. 2023; 14(1):4456. https://doi.org/10.1038/s41467-023-40081-8.

[9] Cui S, Pan XJ, Ge CL, et al. Silybin alleviates hepatic lipid accumulation in methionine-choline deficient diet-induced nonalcoholic fatty liver disease in mice via peroxisome proliferator-activated receptor α. Chin J Nat Med. 2021; 19(6):401-411. https://doi.org/10.1016/S1875-5364(21)60039-0.

[10] Liu X, Xia N, Yu Q, et al. Silybin meglumine mitigates CCl₄-induced liver fibrosis and bile acid metabolism alterations. Metabolites. 2024; 14(10):556. https://doi.org/10.3390/metabo14100556.

[11] Bai Y, Bai Y, Wang S, et al. Targeted upregulation of uncoupling protein 2 within the basal ganglia output structure ameliorates dyskinesia after severe liver failure. Free Radic Biol Med. 2018; 124:40-50. https://doi.org/10.1016/j.freeradbiomed.2018.05.005.

[12] Li D, Yu SF, Lin L, et al. Deficiency of leucine-rich repeat kinase 2 aggravates thioacetamide-induced acute liver failure and hepatic encephalopathy in mice. J Neuroinflammation. 2024; 21(1):123. https://doi.org/10.1186/s12974-024-03125-4.

[13] Hassan NF, El-Ansary MR, El-Ansary AR, et al. Unveiling the protective potential of mirabegron against thioacetamide-induced hepatic encephalopathy in rats: insights into cAMP/PPAR-γ/p-ERK1/2/p S 536 NF-κB p 65 and p-CREB/BDNF/TrkB in parallel with oxidative and apoptotic trajectories. Biochem Pharmacol. 2024; 229:116504. https://doi.org/10.1016/j.bcp.2024.116504.

[14] Wang Y, Yang Z, Wei Y, et al. Apolipoprotein A4 regulates the immune response in carbon tetrachloride-induced chronic liver injury in mice. Int Immunopharmacol. 2021; 90:107222. https://doi.org/10.1016/j.intimp.2020.107222.

[15] Li Y, Li H, Sun M, et al. Silibinin alleviates acute liver failure by modulating AKT/GSK3β/Nrf2/GPX4 pathway. Naunyn Schmiedebergs Arch Pharmacol. 2025; 398(6):7625-7639. https://doi.org/10.1007/s00210-024-03760-x.

[16] Fan X, Wang X, Hui Y, et al. Genipin protects against acute liver injury by abrogating ferroptosis via modification of GPX4 and ALOX15-launched lipid peroxidation in mice. Apoptosis. 2023;28(9-10):1469-1483. https://doi.org/10.1007/s10495-023-01867-9.

[17] Li Y, Xu J, Chen W, et al. Hepatocyte CD36 modulates UBQLN1-mediated proteasomal degradation of autophagic SNARE proteins contributing to septic liver injury. Autophagy. 2023; 19(9):2504-2519. https://doi.org/10.1080/15548627.2023.2196876.

[18] Zhang Y, Xue W, Zhang W, et al. Histone methyltransferase G9a protects against acute liver injury through GSTP1. Cell Death Differ. 2020; 27(4):1243-1258. https://doi.org/10.1038/s41418-019-0412-8.

[19] Kallergi E, Daskalaki AD, Kolaxi A, et al. Dendritic autophagy degrades postsynaptic proteins and is required for long-term synaptic depression in mice. Nat Commun. 2022; 13(1):680. https://doi.org/10.1038/s41467-022-28301-z.

[20] Endicott SJ, Miller RA. PTEN activates chaperone-mediated autophagy to regulate metabolism. Autophagy. 2024; 20(1):216-217. https://doi.org/10.1080/15548627.2023.2255966.

[21] Liang L, Huan L, Wang J, et al. LncRNA RP11-295G 202 regulates hepatocellular carcinoma cell growth and autophagy by targeting PTEN to lysosomal degradation. Cell Discov. 2021; 7(1):118. https://doi.org/10.1038/s41421-021-00339-1.

[22] Zhang L, Zhu Z, Yan H, et al. Creatine promotes cancer metastasis through activation of Smad2/3. Cell Metab. 2021; 33(6):1111-1123. https://doi.org/10.1016/j.cmet.2021.03.009.

[23] Chen S, Ma X, Liu Y, et al. Creatine promotes endometriosis by inducing ferroptosis resistance via suppression of PRP. Adv Sci (Weinh). 2024; 11(38):e2403517. https://doi.org/10.1002/advs.202403517.

[24] Montagnese S, Lauridsen M, Vilstrup H, et al. A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathy. J Hepatol. 2021; 75(1):98-107. https://doi.org/10.1016/j.jhep.2021.03.012.

[25] Munson MJ, Mathai BJ, Ng MYW, et al. GAK andPRKCD kinases regulate basal mitophagy. Autophagy. 2022; 18(2):467-469. https://doi.org/10.1080/15548627.2021.2015154.

[26] Gardin A, Remih K, Gonzales E, et al. Modern therapeutic approaches to liver-related disorders. J Hepatol. 2022; 76(6):1392-1409. https://doi.org/10.1016/j.jhep.2021.12.015.

[27] GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories., 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol2020; 5(3):245-266. https://doi.org/10.1016/S2468-1253(19)30349-8.

[28] Lam P, Cheung F, Tan HY, et al. Hepatoprotective effects of Chinese medicinal herbs: a focus on anti-inflammatory and anti-oxidative activities. Int J Mol Sci. 2016; 17(4):465. https://doi.org/10.3390/ijms17040465.

[29] Yang Q, Tan T, He Q, et al. Combined amphiphilic silybin meglumine nanosuspension effective against hepatic fibrosis in mice mode. Int J Nanomed. 2023; 18:5197-5211. https://doi.org/10.2147/IJN.S407762.

[30] Ding Y, Zhang S, Sun Z, et al. Preclinical validation of silibinin/albumin nanoparticles as an applicable system against acute liver injury. Acta Biomater. 2022; 146:385-395. https://doi.org/10.1016/j.actbio.2022.04.021.

[31] Yang J, Sun Y, Xu F, et al. Silibinin protects rat pancreatic β-cell through up-regulation of estrogen receptors’ signaling against amylin- or Aβ1-42-induced reactive oxygen species/reactive nitrogen species generation. Phytother Res. 2019; 33(4):998-1009. https://doi.org/10.1002/ptr.6293.

[32] Wu X, Chen J, Ping K, et al. Silybin mitigated liver and brain damage after difenoconazole exposure: crosstalk between oxidative stress, inflammation, ferroptosis and apoptosis. Pestic Biochem Physiol. 2024; 202:105942. https://doi.org/10.1016/j.pestbp.2024.105942.

[33] Selc M, Macova R, Babelova A. Novel strategies enhancing bioavailability and therapeutical potential of silibinin for treatment of liver disorders. Drug Des Devel Ther. 2024; 18:4629-4659. https://doi.org/10.2147/DDDT.S483140.

[34] Rahman TM, Hodgson HJ. The effects of early and late administration of inhibitors of inducible nitric oxide synthase in a thioacetamide-induced model of acute hepatic failure in the rat. J Hepatol. 2003; 38(5):583-590. https://doi.org/10.1016/S0168-8278(03)00050-3.

[35] Abo El-Magd NF, El-Kashef DH, El-Sherbiny M, et al. Hepatoprotective and cognitive-enhancing effects of hesperidin against thioacetamide-induced hepatic encephalopathy in rats. Life Sci. 2023; 313:121280. https://doi.org/10.1016/j.lfs.2022.121280.

[36] Eraky SM, El-Kashef DH, El-Sherbiny M, et al. Naringenin mitigates thioacetamide-induced hepatic encephalopathy in rats: targeting the JNK/Bax/caspase-8 apoptotic pathway. Food Funct. 2023; 14(2):1248-1258. https://doi.org/10.1039/d2fo03470k.

[37] Tamnanloo F, Ochoa-Sanchez R, Oliveira MM, et al. Multiple ammonia-induced episodes of hepatic encephalopathy provoke neuronal cell loss in bile-duct ligated rats. JHEP Rep. 2023; 5(12):100904. https://doi.org/10.1016/j.jhepr.2023.100904.

[38] Tan ZK, Chen LF, Ye ZQ, Lu QP. Xiaohuang Qudan decoction alleviates ANIT-induced cholestatic liver injury by inhibiting the JAK2/STAT3 pathway and regulating TH17/Treg. Chin J Nat Med. 2025; 23(4):457-470. https://doi.org/10.1016/S1875-5364(25)60854-5.

[39] Niu TL, Zhu YM, Mou MJ, et al. Identification of natural product-based drug combination (NPDC) using artificial intelligence. Chin J Nat Med. 2025; 23(11):1377-1390. https://doi.org/10.1016/S1875-5364(25)60942-3.

[40] Jalan R, Rose CF.Heretical thoughts into hepatic encephalopathy. J Hepatol. 2022; 77(2):539-548. https://doi.org/10.1016/j.jhep.2022.03.014.

[41] Matyas C, Haskó G, Liaudet L, et al. Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications. Nat Rev Cardiol. 2021; 18(2):117-135. https://doi.org/10.1038/s41569-020-0443-5.

[42] Kumar R, T A, Singothu S, et al. Uncoupling proteins as a therapeutic target for the development of new era drugs against neurodegenerative disorder. Biomed Pharmacother. 2022; 147:112656. https://doi.org/10.1016/j.biopha.2022.112656.

[43] Rangarajan S, Locy ML, Chanda D, et al. Mitochondrial uncoupling protein-2 reprograms metabolism to induce oxidative stress and myofibroblast senescence in age-associated lung fibrosis. Aging Cell. 2022; 21(9):e13674. https://doi.org/10.1111/acel.13674.

[44] Ogando DG, Choi M, Shyam R, et al. Ammonia sensitive SLC4A11 mitochondrial uncoupling reduces glutamine induced oxidative stress. Redox Biol. 2019; 26:101260. https://doi.org/10.1016/j.redox.2019.101260.

[45] Baechler BL, Bloemberg D, Quadrilatero J. Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation. Autophagy. 2019; 15(9):1606-1619. https://doi.org/10.1080/15548627.2019.1591672.

[46] Hwang HJ, Ha H, Lee BS, et al. LC3B is an RNA-binding protein to trigger rapid mRNA degradation during autophagy. Nat Commun. 2022; 13(1):1436. https://doi.org/10.1038/s41467-022-29139-1.

[47] Gao Q, Tian R, Han H, et al. PINK1-mediated Drp1(S616) phosphorylation modulates synaptic development and plasticity via promoting mitochondrial fission. Signal Transduct Target Ther. 2022; 7(1):103. https://doi.org/10.1038/s41392-022-00933-z.

[48] Jacob S, Kosaka Y, Bhatlekar S, et al. Mitofusin-2 regulates platelet mitochondria and function. Circ Res. 2024; 134(2):143-161. https://doi.org/10.1161/CIRCRESAHA.123.322914.

[49] Zong Y, Li H, Liao P, et al. Mitochondrial dysfunction: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024; 9(1):124. https://doi.org/10.1038/s41392-024-01839-8.